Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.2K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.2K
Allergic Reactions02:06

Allergic Reactions

33.2K
Overview
33.2K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

110
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
110
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.5K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Taking the red out of eosinophilic inflammation in COPD.

The Journal of allergy and clinical immunology·2020
Same author

A Sandwich Enzyme-Linked Immunosorbent Assay (ELISA) for the Quantitation of Selected Peanut Proteins in Foods.

Journal of food protection·2019
Same author

Advances in environmental and occupational disorders in 2016.

The Journal of allergy and clinical immunology·2017
Same author

Fungal Sensitivity: New Insights and Clinical Approaches.

The journal of allergy and clinical immunology. In practice·2016
Same author

Advances in environmental and occupational disorders in 2014.

The Journal of allergy and clinical immunology·2015
Same author

Allergic bronchopulmonary aspergillosis.

The journal of allergy and clinical immunology. In practice·2014

Related Experiment Video

Updated: Mar 12, 2026

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

4.0K

Advances in allergen immunotherapy in 2015.

Robert K Bush1

  • 1Division of Allergy, Pulmonary, Critical Care, and Sleep Medicine, University of Wisconsin, Madison, Wis.

The Journal of Allergy and Clinical Immunology
|November 8, 2016
PubMed
Summary

Advances in allergen immunotherapy (AIT) in 2015 focused on improving effectiveness and safety. Research explored optimal treatments, newer administration routes, and biomarkers for monitoring patient progress.

Keywords:
Allergen immunotherapyclinical trialsimmunotherapy

More Related Videos

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

24.1K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

3.1K

Related Experiment Videos

Last Updated: Mar 12, 2026

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

4.0K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

24.1K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

3.1K

Area of Science:

  • Allergy and Immunology
  • Immunotherapy Research

Background:

  • Allergen immunotherapy (AIT) has a long history of use, exceeding 100 years.
  • Ongoing research aims to optimize treatment approaches and elucidate underlying mechanisms of AIT.

Purpose of the Study:

  • To review significant advances in allergen immunotherapy (AIT) during 2015.
  • To discuss improvements in the effectiveness, safety, and mechanisms of sublingual and oral immunotherapy.

Main Methods:

  • Review of international expert guidelines on AIT.
  • Analysis of recent developments in hypoallergenic vaccines, novel administration routes, and therapeutic regimens.
  • Discussion of biomarkers for monitoring immunotherapy.

Main Results:

  • Significant advancements in AIT were reported in 2015.
  • Focus on enhancing safety through hypoallergenic vaccines and improving efficacy via new routes and regimens.
  • Biomarkers are being explored for monitoring treatment effectiveness.

Conclusions:

  • The year 2015 brought notable progress in allergen immunotherapy.
  • Continued research is vital for refining AIT strategies, including safety, efficacy, and monitoring.
  • Addressing unmet needs in AIT remains a key focus for the scientific community.